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Abstract
Background: We report a case of metachronous solitary metastasis of renal cell carcinoma to
the contralateral adrenal gland treated by laparoscopic transperitoneal adrenalectomy.
Case presentation: A 58-year-old man presented to our institution for regular follow up, 2 years
after a right radical nephrectomy with preservation of the ipsilateral adrenal gland, for a primary
renal cell carcinoma. The patient remained asymptomatic but an abdominal computed tomography
scan on follow up revealed a 6.5 × 4 cm 2 mass in the left adrenal gland. A positron emission
tomography scan was also performed to rule out other possible metastases, and a magnetic
resonance imaging scan was used for accurate localization and determination of resectability of the
adrenal tumour. A bone scan, metabolic screen, liver and renal function tests were all within normal
limits. A laparoscopic transperitoneal adrenalectomy was then performed. The postoperative
period was uneventful, and the patient was discharged on postoperative day two. The patient
remains in satisfactory condition and no recurrence or adrenal insufficiency has been observed
during 12 months follow up.
Conclusion: Metachronous contra lateral adrenal metastases from primary renal cell carcinoma
are very rare but should always be suspected in any nephrectomised patient presenting with an
adrenal tumour. Regular follow up in these patients accompanied with computed tomography
imaging may help the surgeon to detect early lesions. Laparoscopic transperitoneal adrenalectomy
is feasible, safe and effective, with minimal trauma to the patient.
Background
Renal cell carcinoma (RCC) may present with distant
metastasis at the time of diagnosis. It has been estimated
that at the time of diagnosis 20% to 50% of patients are
beyond cure, and less than 5% of those with metastatic
disease are alive at 5 years [1]. However, it has been
reported that improved survival can be achieved when
solitary metastases are excised together with the primary
RCC [2]. Adrenal metastases from RCC are frequently
found at autopsy [3]. These lesions tend to be detected
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synchronously with the renal tumour, and only a few are
detected metachronously on follow up after nephrectomy
[3].
In recent years, the laparoscopic approach has been
reported to offer the well-known benefits of minimally
invasive surgery over the traditional open technique for
adrenal tumours, and can be performed either transperi-
toneally or retroperitoneally [4]. The transperitoneal
approach is reserved for malignant adrenal disease as it
has the benefit of a wider working space and readily iden-
tifiable anatomical landmarks [5]. It might be assumed
that the benefits of the laparoscopic approach for primary
adrenal tumours could be applied for metastatic adrenal
disease as well. We report a case of laparoscopic transperi-
toneal adrenalectomy in a patient with metachronous sol-
itary metastasis of RCC to the contra lateral adrenal gland.
Case presentation
A 58-year-old man presented to our institution for regular
follow up, 2 years after a right radical nephrectomy for a
primary RCC. The patient remained asymptomatic but an
abdominal computed tomography (CT) scan on follow
up revealed a homogeneous 6.5 × 4 cm2 mass in the left
adrenal gland with no calcification (Figure 1). Further-
more, the positron emission tomography scan revealed a
fluorodeoxyglucose (FDG)-avid enlarged left adrenal
gland, with no evidence of FDG-avid para-aortic lym-
phadenopathy or any further abnormality of the right
renal bed or adjacent areas. Radiological studies (abdom-
inal and chest CT scan) before the radical nephrectomy
had revealed a 12 cm heterogeneous soft tissue mass in
mid pole in the right kidney consistent with an RCC.
There was no involvement of the inferior vena cava or
right renal vein and no evidence of distant metastases at
that point. The patient then underwent a transperitoneal
laparoscopic radical nephrectomy of the right kidney with
preservation of the ipsilateral adrenal gland. The pathol-
ogy report of the nephrectomy specimen had shown a
Fuhrman grade 2 stage T2 (T2N0M0) RCC.
After the detection of the left adrenal tumour on follow
up, the patient was admitted for further investigation and
management. A MRI scan was used for accurate localiza-
tion and determination of resectability of the adrenal
tumour. A bone scan for metastatic evaluation was unre-
markable. Laboratory tests, including full blood count,
electrolytes, complete metabolic screen, liver and renal
function were all within normal limits. In particular, met-
abolic evaluation included 24-hour urine collections for
17-ketosteroids, 17-hydrocorticoids, metanephrines, cor-
tisol and vanillylmandelic acid, which were within nor-
mal limits. The American Society of Anesthesiologists
(ASA) grade of the patient was III. Based on these findings
and through a multidisciplinary team meeting, a laparo-
scopic transperitoneal adrenalectomy was considered for
this patient.
After induction of general anaesthesia, a urinary catheter
and a nasogastric tube were inserted. The patient was
placed in the lateral decubitus position with the left side
up. After creating the pneumoperitoneum, a 30° laparo-
scope was inserted and three additional working ports
(5,5 and 10 mm) were placed under direct vision. A plane
was established along the anterior surface of the left kid-
ney, just lateral and dorsal to the spleen and tail of pan-
creas. This was accomplished by incising the splenorenal
ligament and mobilizing the spleen laterally; the superior
pole of the kidney and the adrenal gland with the tumour
were thus exposed. The dissection along the anterior sur-
face of the kidney and adrenal continued until the inferior
pole and medial border of the adrenal was exposed. This
allowed identification of the dissection plane between the
anterior surface of the kidney and the inferior border of
the adrenal. The dissection was continued along the infe-
rior and medial aspect of the adrenal, staying close to the
gland until the left adrenal vein was isolated and clipped.
Final dissection and gland excision progressed from
medial to lateral and inferior to superior. Before specimen
extraction, the operative field was carefully inspected for
haemostasis. Once haemostasis was ensured, the adrenal
CT scan showing an adrenal metastasis to the contralateral  gland, 2 years after a right nephrectomy for primary RCC Figure 1
CT scan showing an adrenal metastasis to the con-
tralateral gland, 2 years after a right nephrectomy 
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gland with the tumour was placed in a specimen retrieval
sac and removed through a 10 mm trocar site. The opera-
tion was completed by releasing the pneumoperitoneum
and closing the fascia of the 10 mm trocar site with
absorbable sutures.
The histological examination of the specimen demon-
strated a metastatic RCC with features similar to the pri-
mary renal tumour. All surgical margins were free of
tumour. The specimen weighed 62 g and measured 6.5 ×
4 × 3 cm3. The postoperative period was uneventful, and
the patient was discharged on postoperative day two. The
patient is well and has no recurrence or adrenal insuffi-
ciency 18 months post-surgery.
Discussion
Approximately 25% of patients with RCC will already
have multiple distant metastases at the time of presenta-
tion, including the lungs (55%), lymph nodes (38%),
liver (35%) or bones (33%) [1]. Adrenal metastases from
RCC are not uncommon, with autopsy studies showing
an incidence of 6% to 23% [3]. However, in nephrect-
omised patients the incidence of solitary adrenal metasta-
sis is 3% to the ipsilateral gland and only 0.7% to the
contra lateral gland [6].
It has been suggested that the anatomic relationship
between the kidney and the adrenal gland on the left side
with common venous and lymphatic drainage predis-
poses towards adrenal gland metastases in left sided
tumours [7]. With primary RCC it is believed that haema-
togenous metastasis to the adrenal gland is more com-
mon than direct extension, due to the rich blood supply
of the adrenal gland and its high blood volume-to-unit
weight ratio [7]. However, the underlying biological path-
way for contralateral adrenal metastases (CAM) by RCC is
still unknown [8]. Of interest, a published series of
patients with metastatic spread to the contra lateral adre-
nal gland or kidney showed an 80% incidence of involve-
ment of the renal vein or inferior vena cava by the primary
tumour [9]. In our case, preoperative imaging of the RCC
before radical nephrectomy had not revealed any involve-
ment of the inferior vena cava or the right renal vein.
Adrenal metastases are usually anatomically and func-
tionally silent, and patients rarely have symptoms or signs
of adrenal insufficiency. Thus, if abdominal imaging is
not used routinely during the follow up, an isolated adre-
nal metastasis from RCC could be missed during life [7].
A solitary metastasis to the contra lateral adrenal gland
can cause confusion, particularly since the histological
status maybe unclear [9]. The optimal diagnostic
approach to a solitary contra lateral adrenal tumour in
patients with a history of RCC is contentious and seems to
differ from the management of 'incidentalomas' [8]. Radi-
ological studies may facilitate the preoperative diagnosis
but cannot determine with certainty whether an adrenal
tumour in a patient with RCC is a primary adrenal neo-
plasm, an adrenal cortical adenoma or a metastasis [8].
The preoperative diagnosis of CAM begins with high sus-
picion based on a history of RCC. In these patients, the
findings of a solitary adrenal tumour without elevated
serum adrenocortical hormones are strongly suggestive of
a metastatic lesion to the adrenal gland [7,9]. In our case,
the normal metabolic screen and the recent history of
RCC suggested adrenal metastasis as the most likely diag-
nosis.
The remote risk of developing CAM after primary radical
nephrectomy supports the idea of sparing the adrenal
gland in suitable patients who undergo radical nephrec-
tomy [10]. Sparing the ipsilateral adrenal gland in radical
nephrectomy would avoid the risk of adrenal insuffi-
ciency if the development of a tumour requires removal of
the contra lateral adrenal gland, either at the time of
nephrectomy or later [10]. The need for routine adrenal-
ectomy during radical nephrectomy is questionable as the
risk of an ipsilateral adrenal tumour developing after rad-
ical nephrectomy is low (3%). The only exception would
be for tumours localized in the upper pole of the kidney
and close to the adrenal gland [10].
Surgical removal is the only known effective treatment in
patients with solitary adrenal metastasis, with 29% to
35% of them surviving 5 years or more [11]. Plawner
showed that the 5-year survival of patients operated on for
metachronous solitary RCC metastases to the contra lat-
eral adrenal gland was lower than that for patients with
synchronous adrenal metastases (20% and 40%, respec-
tively) [11]. It has also been noted that patients diagnosed
with adrenal metastasis a long time after nephrectomy
had a better prognosis than those with a short interval to
diagnosis [1]. Among patients who undergo nephrectomy
and resection of solitary metastases, it has been reported
that 30% have prolonged survival, many of them for more
than 5 years. Therefore, aggressive treatment-excision of
such lesions is indicated [2,11].
Because of the anatomical position of the adrenal gland
and the small size of the lesions, laparoscopic adrenalec-
tomy is an interesting approach to adrenal surgery. Stud-
ies comparing the laparoscopic and the open
adrenalectomy reported statistically significant benefits in
the laparoscopic group regarding the hospital stay, analge-
sic requirements, blood loss, return to normal activity and
patient satisfaction [12]. Preliminary reports showed that
these minimally invasive procedures may advantageously
replace open surgery for removal of unilateral or bilateral
tumours of the adrenal gland of less than 7 cm [5]. How-Publish with BioMed Central    and   every 
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ever, successful laparoscopic resections of tumours meas-
uring up to 15 cm have also been reported [4].
There are four laparoscopic approaches to the adrenal
gland, namely transperitoneal, lateral retroperitoneal,
posterior retroperitoneal and transthoracic transdiaphrag-
matic. The transperitoneal approach was used first and is
still the most popular technique as it provides a more
ample working cavity, greater visibility and better instru-
ment mobility [4]. The retroperitoneal approaches are
preferred in patients with history of upper abdominal sur-
gery and unilateral adrenal tumours less than 5 cm in
diameter. Particularly in the case of adrenal cancer or phe-
ochromocytoma, the transperitoneal adrenalectomy is
considered the approach of choice, because of the wide
exposure and as it allows inspection of extra-adrenal sites
and 'en bloc' excision in case of extended disease [5]. In
our case, the adrenal metastasis measured 6.4 × 4 cm2 in
preoperative imaging and was resected successfully
through a laparoscopic transperitoneal approach, in a
patient with a previous history of transperitoneal laparo-
scopic radical nephrectomy of the contra lateral kidney.
Conclusion
Metachronous CAM from primary RCC are very rare but
should always be suspected in any nephrectomised
patient presenting with an adrenal tumour. Regular fol-
low up in these patients with CT or MRI imaging may help
the surgeon to detect these lesions early. Laparoscopic
transperitoneal adrenalectomy seems to be a feasible, safe
and effective approach for these rare cases.
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